|
BMRN
|
BioMarin Pharmaceutical Inc.
|
6.09%
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
5.21%
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
5.17%
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
5.06%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.95%
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
4.74%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
4.56%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
4.56%
|
US
|
NASDAQ
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
3.39%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
3.12%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
3.08%
|
US
|
NASDAQ
|
|
VCEL
|
Vericel Corporation
|
3.03%
|
US
|
NASDAQ
|
|
EBS
|
Emergent Biosolutions, Inc.
|
2.97%
|
US
|
NYSE
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
2.92%
|
US
|
NASDAQ
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
2.91%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
2.84%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
2.83%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
2.82%
|
US
|
NASDAQ
|
|
QGEN
|
Qiagen N.V.
|
2.80%
|
US
|
NYSE
|
|
CDMO
|
Avid Bioservices, Inc.
|
2.77%
|
US
|
NASDAQ
|